| Title： | Chinese expert consensus on pharmacotherapy and pharmaceutical care for atopic dermatitis |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Treatment |
| Countries and regions： | China |
| Guidelines users： | Pharmacists and relevant medical personnel in medical institutions at all levels |
| Evidence classification method： | OCEBM |
| Development unit： | Chinese Pharmaceutical Association Hospital Pharmacy Professional Committee |
| Registration time: | 2023-05-06 |
| Registration number： | PREPARE-2023CN355 |
| Purpose of the guideline: | This consensus aims to standardize the drug use and pharmaceutical care of clinical pharmacists in atopic dermatitis (AD) management, improve the therapeutic effect, medication safety, patient compliance and satisfaction, and thus promote the high quality of AD management in China. |
